Please paraphrase the text
Neuroleptic Malignant Syndrome, characterised by hyperthermia, muscle rigidity, autonomic instability, altered consciousness and elevated serum creatine phosphokinase levels, has been reported to occur with antipsychotics including lurasidone.
Neuroleptic malignant disorders have been reported with an antipsychotic treatment, including lurasidone, with hyperthermia, muscular rigidity, autonomous instability, consciousness disturbances and increased serum creatine phosphokinase levels.